Dr Bhanu Singh is a board-certified veterinary anatomic pathologist (DACVP) and toxicologist (DABT) and is also a Fellow of International Academy of Toxicologic Pathology (IATP). In his current role as Senior Director at Gilead Sciences, Dr. Singh leads the pathology support of nonclinical safety studies for virology portfolio. He also serves as the project toxicologist for long-acting injectable programs and as subject matter expert on internal working groups for issues related to the development of long-acting injectable programs. Dr Singh has been involved with ESTP activities in the past and currently co-leading the ESTP expert workshop on long acting injectables. He is also a member of Pathology 2.0 working group (Mass Spectrometry Imaging).
With over 15 years of industry experience, his most recent position was as the Scientific Director of Pathology at Janssen Pharmaceuticals, where he supported nonclinical safety programs for Oncology and Cardiovascular & Metabolic Diseases. Dr. Singh has a strong scientific interest in drug discovery (virology, oncology and cardiovascular metabolism), Mass Spectrometry Imaging, liver toxicity, and chemical carcinogenesis. He has authored over 25 peer-reviewed publications, five book chapters, and 100+ regulatory and research pathology reports and delivered more than 75 presentations in various scientific meetings. Dr. Singh has actively served in various professional societies and consortia, such as Chair for the STP education course committee, president of SOT specialty section (CTPVSS), Associate Editor for Drug and Chemical Toxicology, Chair for the IFSTP-IATP webinar committee, and Chair for international toxicologic pathology nomenclature initiative (INHAND) of rodent liver pathology.
Dr. Singh completed his pathology residency training at the Royal Veterinary College in London under the guidance of Dr Luann Mckinney. During his residency training, he completed externships at Bern University in Switzerland, the University of California, Davis in United States, the Armed Force Institute of Pathology in Washington, DC and the National Institute of Environmental Health Sciences (NIEHS). After finishing his residency, he worked at NIEHS/NTP (Research Triangle Park, North Carolina) as a Visiting Fellow in Dr. Dave Malarkey’s laboratory. He received his veterinary training at G. B. Pant University in Pantnagar, India and earned a master’s degree in Pathology at Utrecht University in the Netherlands.